https://www.thebodypro.com/category/hiv-prevention-methods/tag/women

The Latest

Mexico City's Downtown At Twilight

IAS 2019: What to Expect in HIV Science

Next week, 6,000 HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.

Contraception pills on blue background

This Week in HIV Research: Cracking the Contraception Conundrum

July 11, 2019: Seroconversion while on long-acting contraceptives; cardiovascular risk in people with HIV; suboptimal testing in high-prevalence U.S. areas; E/C/F/TAF may be suitable for PEP.

Woman biting into apple

This Week in HIV Research: A Bite of the Apple

June 20, 2019: Housing stability and HIV viremia; how the stigma of poverty affects viral load; the best time to employ syringe services; promise for the practice of index testing.

AIDS Activists Hold March And Rally In New York City

Ending the HIV Epidemic Will Take More Than Medicine

Our HIV research agenda has to address the world outside of a clinical trial, vaccine researcher Stephaun E. Wallace, Ph.D., argues.

scientists in Vaccine Research Center at National Institutes of Health

Making Trans Women Count in HIV Vaccine Trials

"For us who focus on HIV prevention research, it is paramount that we go where the epidemic is in this country," said Michele Andrasik, Ph.D.

Fleur De Kine

New Campaign, Toolkit Gets Providers PrEP'd for Women

New York City aims to expand PrEP and PEP access by educating more clinicians that serve women.

This Week in HIV Research: Fentanyl Smooths the Path for HIV

April 4, 2019: what’s driving the HIV outbreak in northeastern Massachusetts; race-gender HIV disparities among Baltimore sex workers; high PrEP interest, low awareness among southern black women; naltrexone implants for opioid dependence.

This Week in HIV Research: Prevention and Treatment in the Real World

Impact of intimate partner violence on PrEP attitudes among women; evolution of first-line HIV treatment failure rates; cumulative low-level viremia and virologic failure risk; HIV drug levels in breast milk versus plasma.

Drug Use May Be Increasing Syphilis Rates Among HIV-Positive Cisgender Women, Studies Show Img

Drug Use May Be Increasing Syphilis Rates Among HIV-Positive Cisgender Women, Studies Show

The global increase in sexually transmitted infections was a major focus of the CROI 2019 meeting in Seattle, Washington.

Internal Condom

'Female Condom' Gets a Genderless Rebrand From FDA

After years of pressure from prevention advocates, FDA has finally given the other rubber a new name - the internal condom – and a new classification.